高级检索

阿奇霉素序贯疗法对于促进支原体肺炎患儿症状改善及安全性的临床效果分析

Clinical effect of Azithromycin sequential therapy on children with mycoplasma pneumonia in symptomatic improvementand security

  • 摘要: 目的 探讨阿奇霉素序贯疗法对于促进支原体肺炎患儿症状改善及安全性的临床效果分析。方法 选取2015年2月-2016年8月在广东省妇幼保健院确诊患有支原体肺炎的100例患儿,以就诊号随机数字法将其分为阿奇霉素组及红霉素组,每组各50例。阿奇霉素组50例患儿进行静脉滴注阿奇霉素治疗,红霉素组50例患儿予以常规静脉滴注红霉素进行治疗。比较两组患儿治疗后的疗效、临床症状消失时间、住院时间和不良反应发生情况。结果 患儿临床治疗总有效率阿奇霉素组为95.0%,显著高于红霉素组(55.0%);阿奇霉素组患者的啰音消失时间、咳嗽消失时间、发热消退时间,以及总住院时间均显著少于红霉素组;患儿不良反应发生率红霉素组(32%)明显高于阿奇霉素组(10%)。两组比较差异均具有统计学意义(P<0.05)。结论 阿奇霉素序贯疗法治疗支原体肺炎,能够显著缓解患儿的临床症状,起效快,总住院时间缩短,不良反应发生率减少,值得临床推广。

     

    Abstract: Objective To investigate the clinical effect of azithromycin sequential therapy on children with mycoplasma pneumonia in symptomatic improvementand security.Methods During February 2015 to August 2016,100 children who was diagnosed with mycoplasma pneumoniain in Maternal and child health hospital of Guangdong province were selected,and they were divided into azithromycin group and erythromycin group by random numbers according their number for see the doctor,each 50 cases in each group,the azithromycin group were treated with azithromycin,and the erythromycin group were treated with erythromycin,and the effect,extinction time of the clinical symptoms,hospital stays and adverse reaction were compared between the two groups.Results The effective rate of azithromycin group was 95%,which was higher than that in erythromycin group(55.0%). The extinction time of rale,cough and fever was shorter in azithromycin group than those in erythromycin group,and the time of hospital stays and adverse reaction were also shorter in azithromycin group than those in erythromycin group(P<0.05).Conclusion Azithromycin sequential therapy can remit the clinic symptomatic of children with mycoplasma pneumonia,and the method had the characteristic of fast effect,short the time of hospital stays and decrease the adverse reaction,it is worthy of clinical application.

     

/

返回文章
返回